Among the cellular milieu, a molecular mechanism is highlighted: NLRP3 inflammasome activation and its ensuing products are highly present in the BAL, sputum and lung tissues of COPD patients. This evidence concerns the gene NLRP3 and chronic obstructive pulmonary disease.